Publicacións en colaboración con investigadores/as de Mutua de Terrassa (24)

2024

  1. Predicting the Length of Mechanical Ventilation in Acute Respiratory Disease Syndrome Using Machine Learning: The PIONEER Study

    Journal of Clinical Medicine, Vol. 13, Núm. 6

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Effects of intubation timing in patients with COVID-19 throughout the four waves of the pandemic: a matched analysis

    The European respiratory journal, Vol. 61, Núm. 3

  3. Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients

    Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 205-215

2022

  1. Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study

    Intensive Care Medicine, Vol. 48, Núm. 7, pp. 850-864

  2. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

2021

  1. Correction to: The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients (Critical Care, (2021), 25, 1, (331), 10.1186/s13054-021-03727-x)

    Critical Care

  2. The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients

    Critical Care, Vol. 25, Núm. 1

2020

  1. Contingency plan for the intensive care services for the COVID-19 pandemic

    Medicina Intensiva, Vol. 44, Núm. 6, pp. 363-370

  2. Recommendations for specialized nutritional-metabolic management of the critical patient: introduction, methodology and list of recommendations. Metabolism and Nutrition Working Group of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC)

    Medicina Intensiva, Vol. 44, pp. 1-14

2018

  1. Application of BioFire FilmArray Blood Culture Identification panel for rapid identification of the causative agents of ventilator-associated pneumonia

    Clinical Microbiology and Infection, Vol. 24, Núm. 11, pp. 1213.e1-1213.e4

  2. Improved empirical antibiotic treatment of sepsis after an educational intervention: The ABISS-Edusepsis study

    Critical Care, Vol. 22, Núm. 1

  3. Is overall mortality the right composite endpoint in clinical trials of acute respiratory distress syndrome?

    Critical Care Medicine, Vol. 46, Núm. 6, pp. 892-899

2016

  1. Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome

    Critical Care, Vol. 20, Núm. 1

2015

  1. Safety and efficacy of colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia as part of a macro-project funded by the Seventh Framework Program of the European Commission studying off-patent antibiotics: Study protocol for a randomized controlled trial

    Trials, Vol. 16, Núm. 1

2013

  1. A review of the factors influencing antimicrobial prescribing

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 31, Núm. SUPPL. 4, pp. 12-15

2012

  1. Programas de optimización de uso de antimicrobianos (PROA) en hospitales españoles: documento de consenso GEIH-SEIMC, SEFH y SEMPSPH

    Farmacia Hospitalaria, Vol. 36, Núm. 1

  2. Programas de optimización de uso de antimicrobianos (PROA) en hospitales españoles: documento de consenso GEIH-SEIMC, SEFH y SEMPSPH

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 30, Núm. 1

2011

  1. Community-acquired respiratory coinfection in critically III patients with pandemic 2009 influenza A(H1N1) virus

    Chest, Vol. 139, Núm. 3, pp. 555-562

  2. Impact of obesity in patients infected with 2009 influenza A(H1N1)

    Chest, Vol. 139, Núm. 2, pp. 382-386